Advertisement

Topics

Kala nets $66.9mm via FOPO

19:40 EDT 4 Oct 2018 | Elsevier Business Intelligence

Ophthalmic-focused Kala Pharmaceuticals Inc. netted $66.9mm through the follow-on public offering of 8.6mm common shares (inc...

Original Article: Kala nets $66.9mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "Kala nets $66.9mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...